Mayra Orrillo

459 total citations
7 papers, 269 citations indexed

About

Mayra Orrillo is a scholar working on Pulmonary and Respiratory Medicine, Oncology and Surgery. According to data from OpenAlex, Mayra Orrillo has authored 7 papers receiving a total of 269 indexed citations (citations by other indexed papers that have themselves been cited), including 5 papers in Pulmonary and Respiratory Medicine, 5 papers in Oncology and 2 papers in Surgery. Recurrent topics in Mayra Orrillo's work include Cancer Immunotherapy and Biomarkers (4 papers), Immunotherapy and Immune Responses (2 papers) and Prostate Cancer Treatment and Research (2 papers). Mayra Orrillo is often cited by papers focused on Cancer Immunotherapy and Biomarkers (4 papers), Immunotherapy and Immune Responses (2 papers) and Prostate Cancer Treatment and Research (2 papers). Mayra Orrillo collaborates with scholars based in Spain and United States. Mayra Orrillo's co-authors include Sonia Candamio, Mar Iglesias, Daniel L. Edelstein, Francisca Vázquez, Beatríz Bellosillo, Laura Visa, Marta Guix, Frederick S. Jones, Joan Albanell and Alba Dalmases and has published in prestigious journals such as Journal of Clinical Oncology, British Journal of Cancer and Annals of Oncology.

In The Last Decade

Mayra Orrillo

5 papers receiving 267 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
Mayra Orrillo Spain	3	229	186	151	98	42	7	269
Carmela Rodríguez Spain	3	239 1.0×	191 1.0×	151 1.0×	98 1.0×	54 1.3×	5	285
Lisa Dobbyn United States	4	185 0.8×	140 0.8×	110 0.7×	67 0.7×	56 1.3×	7	234
Lizhen Zhu China	8	127 0.6×	135 0.7×	113 0.7×	91 0.9×	59 1.4×	18	273
Tenna Vesterman Henriksen Denmark	10	316 1.4×	206 1.1×	151 1.0×	123 1.3×	75 1.8×	22	359
Melanie Schrumpf Netherlands	7	135 0.6×	137 0.7×	117 0.8×	112 1.1×	84 2.0×	8	308
Amanda Frydendahl Denmark	7	190 0.8×	139 0.7×	95 0.6×	65 0.7×	44 1.0×	15	228
Iris Faull Spain	8	268 1.2×	198 1.1×	125 0.8×	152 1.6×	97 2.3×	22	370
Eisaku Furukawa Japan	5	184 0.8×	173 0.9×	80 0.5×	78 0.8×	99 2.4×	7	274
Erica Bonazzina Italy	9	127 0.6×	262 1.4×	112 0.7×	107 1.1×	62 1.5×	24	333
Joseph M. Guenther United States	2	287 1.3×	242 1.3×	84 0.6×	96 1.0×	56 1.3×	2	366

Countries citing papers authored by Mayra Orrillo

Since Specialization

Citations

This map shows the geographic impact of Mayra Orrillo's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Mayra Orrillo with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Mayra Orrillo more than expected).

Fields of papers citing papers by Mayra Orrillo

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Mayra Orrillo. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Mayra Orrillo. The network helps show where Mayra Orrillo may publish in the future.

Co-authorship network of co-authors of Mayra Orrillo

This figure shows the co-authorship network connecting the top 25 collaborators of Mayra Orrillo. A scholar is included among the top collaborators of Mayra Orrillo based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Mayra Orrillo. Mayra Orrillo is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

7 of 7 papers shown

1.

Muñoz‐Couselo, Eva, Ana Arance, Mayra Orrillo, et al.. (2025). Adjuvant Immunotherapy After Resected Melanoma: Survival Outcomes, Prognostic Factors and Patterns of Relapse. Cancers. 17(1). 143–143.

2.

Rodríguez‐Vida, Alejo, Pablo Maroto, Albert Font, et al.. (2022). Safety and efficacy of avelumab plus carboplatin in patients with metastatic castration-resistant prostate cancer in an open-label Phase Ib study. British Journal of Cancer. 128(1). 21–29. 9 indexed citations

3.

Jiménez, Natàlia, Òscar Reig, Giancarlo Castellano, et al.. (2020). 1971P Neuroendocrine (NE) expression profiling in non-castrate tumours is associated with poor therapy benefit and adverse clinical outcome in metastatic castration-resistant prostate cancer (mCRPC) patients. Annals of Oncology. 31. S1107–S1107.

4.

Rocha, Pedro, Mayra Orrillo, Álvaro Taus, et al.. (2020). Comparison of Different Methods for Defining Hyperprogressive Disease in NSCLC. JTO Clinical and Research Reports. 2(1). 100115–100115. 3 indexed citations

5.

Rodríguez, A., Mayra Orrillo, Natàlia Jiménez, et al.. (2020). Response to immunotherapy, platinum-based chemotherapy or their combination in metastatic urothelial carcinoma (MUC) with or without FGFR-3 alterations: Single cohort experience.. Journal of Clinical Oncology. 38(6_suppl). 560–560. 1 indexed citations

6.

Orrillo, Mayra, et al.. (2018). Radiological identification of rapid progressions in advanced NSCLC patients treated with nivolumab. Annals of Oncology. 29. viii534–viii534. 1 indexed citations

7.

Vidal, Joana, Alba Dalmases, Frederick S. Jones, et al.. (2017). Plasma ctDNA RAS mutation analysis for the diagnosis and treatment monitoring of metastatic colorectal cancer patients. Annals of Oncology. 28(6). 1325–1332. 255 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact